Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Cost-Effectiveness and Cost-Utility of Statin Drug for the Treatment of Patients With Cardiovascular Disease, a Systematic Review Publisher



Eisavi M1 ; Mazaheri E3 ; Rezapour A2 ; Vahedi S5 ; Hadian M4 ; Jafari A6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Economics, Allameh Tabataba'i University, Tehran, Iran
  2. 2. Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medical Library and Information Sciences, Health Information Technology Research Center, Student Research Committee, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Health Care Management, Health Management and Economics Research Center, Student Research Committee, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Health Services Management, School of Health, Ahvaz University of Medical Sciences, Ahvaz, Iran
  6. 6. Health Human Resources Research Centre, School of Management and Medical Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

Source: International Journal of Preventive Medicine Published:2021


Abstract

Cardiovascular diseases impose a burden of disease and economic burden on society. With regard to different drugs are used to treat cardiovascular disease; these interventions should be economically evaluated and them that the most cost-effective were selected. The aim of this study was to investigate the studies carried on the cost-effectiveness and cost-utility of statin drugs for the treatment of patients with cardiovascular disease between 2004 and 2020. Quality assessment of the articles was examined by Drummond's checklist. Given that the inclusion criteria, 26 articles included in the review. The results of this review showed that many articles related to the economic evaluation of statin drugs adhered international standards for performing economic evaluation studies. All the studies mentioned the source of effectiveness (the second criteria) and alternative options for the comparison (the third criteria). Atorvastatin and rosuvastatin drugs were the main options for the comparison in the studies. Although the results of the studies were different in some aspects, such as the type of modeling, costs items and the study perspective, they reached the same results which the use of statin drugs versus no-drug can decrease cost, cardiovascular events and deaths and increase QALY. The results were nearly different due to study design, time horizon, efficacy, and drug prices. © 2021 International Journal of Preventive Medicine | Published by Wolters Kluwer - Medknow
Related Docs
View other Related Docs
1. Model-Based Cost-Effectiveness Analysis of Atorvastatin Drugs for Prevention of Cardiovascular Diseases in Iran, International Journal of Preventive Medicine (2020)
2. Cost-Effectiveness and Cost-Utility Analysis of Otc Use of Simvastatin 10 Mg for the Primary Prevention of Myocardial Infarction in Iranian Men, DARU, Journal of Pharmaceutical Sciences (2015)
3. Cost-Utility Analysis of Combination Medical Therapies in Chronic Coronary Syndrome: A Comparative Study Using Real-World and Patient-Level Data From Iran, BMJ Open (2025)
4. Variations in Common Diseases, Hospital Admissions, and Deaths in Middle-Aged Adults in 21 Countries From Five Continents (Pure): A Prospective Cohort Study, The Lancet (2020)
5. Total Cardiovascular Risk Approach to Improve Efficiency of Cardiovascular Prevention in Resource Constrain Settings, Journal of Clinical Epidemiology (2011)
6. Economic Burden of Hepatitis B at Different Stages of the Disease: A Systematic Review Study, International Journal of Preventive Medicine (2024)
7. Changes in the Burden and Underlying Causes of Heart Failure in the Eastern Mediterranean Region, 1990–2019: An Analysis of the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
8. The Cost-Effectiveness and Cost-Utility Analysis of the Use of Enoxaparin Compared With Heparin for Venous Thromboembolism Prophylaxis in Medical Inpatients in Iran, DARU, Journal of Pharmaceutical Sciences (2019)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (5)
Roya Kelishadi (4)
Other Related Docs
9. Anti-Inflammatory Effects of Different Statins in Rheumatoid Arthritis; a Randomized Double-Blind Controlled Clinical Trial, Immunopathologia Persa (2019)
10. Availability and Affordability of Medicines and Cardiovascular Outcomes in 21 High-Income, Middle-Income and Low-Income Countries, BMJ Global Health (2020)
11. Cost-Effectiveness Evaluation of Aspirin in Primary Prevention of Myocardial Infarction Amongst Males With Average Cardiovascular Risk in Iran, Research in Pharmaceutical Sciences (2017)
12. Secondary Prevention Medications in 17 Countries Grouped by Income Level (Pure): A Prospective Cohort Study, Journal of the American College of Cardiology (2025)
13. Statins Use and Risk of Breast Cancer Recurrence and Death: A Systematic Review and Meta-Analysis of Observational Studies, Journal of Pharmacy and Pharmaceutical Sciences (2016)
14. Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Diseases (Polyiran): A Pragmatic, Cluster-Randomised Trial, The Lancet (2019)
15. The Use and the Cost of Outpatient Diagnostic Procedures for Cardiovascular Diseases in Isfahan Province: A Utilization Study, Journal of Education and Health Promotion (2022)
16. Polypill for the Prevention of Cardiovascular Disease (Polyiran): Study Design and Rationale for a Pragmatic Cluster Randomized Controlled Trial, European Journal of Preventive Cardiology (2015)
17. Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-Income, Middle-Income, and Low-Income Countries: An Analysis of the Pure Study Data, The Lancet (2016)
18. The Effects of Statins on Dental and Oral Health: A Review of Preclinical and Clinical Studies, Journal of Translational Medicine (2020)
19. The Effect of Statins on C-Reactive Protein in Stroke Patients: A Systematic Review of Clinical Trials, Mediators of Inflammation (2021)
20. Atherosclerosis and Statins, Journal of Isfahan Medical School (2011)
21. The Effect of Statin Therapy in Stroke Outcome: A Double Blind Clinical Trial, International Journal of Preventive Medicine (2012)
22. Protective Effects of Coenzyme Q10 and L-Carnitine Against Statin-Induced Pancreatic Mitochondrial Toxicity in Rats, Research in Pharmaceutical Sciences (2017)
23. Ethnicity Based Differences in Statin Use and Hypercholesterolemia Control Among Patients With Premature Coronary Artery Disease-Results of I-Pad Study, International Journal of Cardiology: Cardiovascular Risk and Prevention (2023)
24. Adherence to Statin Therapy in Patients With Type 2 Diabetes: An Important Dilemma, Journal of Research in Medical Sciences (2015)
25. Use of Secondary Prevention Drugs for Cardiovascular Disease in the Community in High-Income, Middle-Income, and Low-Income Countries (The Pure Study): A Prospective Epidemiological Survey, The Lancet (2011)